HKMPY - Hikma Pharmaceuticals PLC

Other OTC - Other OTC Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
188,000
188,000
421,000
431,000
486,000
Depreciation & amortisation
193,000
193,000
145,000
91,000
99,000
Stock-based compensation
22,000
22,000
29,000
27,000
24,000
Change in working capital
-131,000
-131,000
-30,000
-208,000
-44,000
Inventory
-102,000
-102,000
38,000
-180,000
-25,000
Other working capital
305,000
305,000
409,000
240,000
286,000
Other non-cash items
71,000
78,000
39,000
22,000
1,000
Net cash provided by operating activities
530,000
530,000
638,000
464,000
472,000
Cash flows from investing activities
Investments in property, plant and equipment
-225,000
-225,000
-229,000
-224,000
-186,000
Acquisitions, net
-380,000
-380,000
-17,000
-60,000
-8,000
Purchases of investments
-15,000
-15,000
-3,000
-5,000
-6,000
Sales/maturities of investments
0
0
6,000
2,000
14,000
Other investing activities
-
-
3,000
-3,000
-
Net cash used for investing activities
-607,000
-607,000
-238,000
-283,000
-151,000
Net change in cash
-135,000
-135,000
113,000
-117,000
166,000
Cash at beginning of period
426,000
426,000
323,000
442,000
276,000
Cash at end of period
270,000
270,000
426,000
323,000
442,000
Free cash flow
Operating cash flow
530,000
530,000
638,000
464,000
472,000
Capital expenditure
-225,000
-225,000
-229,000
-224,000
-186,000
Free cash flow
305,000
305,000
409,000
240,000
286,000